Study of SHR-A1921 in Combination With Other Anti-cancer Agents in Patients With Advanced Solid Tumors
Clinical trial NCT05765032 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05765032
- Sponsor
- Suzhou Suncadia Biopharmaceuticals Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-30
- Primary completion
- 2025-04-30
- Enrollment
- 220
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.